PDGFR inhibitors function by binding to the tyrosine kinase domain of the receptor, thereby preventing its activation. This inhibition blocks downstream signaling pathways that are responsible for cancer cell proliferation and survival. By targeting these receptors, PDGFR inhibitors can effectively reduce tumor growth and metastasis.
